Jakub Cvek

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 174 citations · Full text

Concurrent Chemoradiotherapy, Neoadjuvant Therapy, Squamous Cell Carcinoma +6

Stereotactic radiosurgery for ablation of ventricular tachycardia

Radek Neuwirth, Jakub Cvek, Lukáš Knybel et al. · EP Europace · 2019 · 170 citations · Full text

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

Domenica Lorusso, Yang Xiang, Kosei Hasegawa et al. · The Lancet · 2024 · 130 citations

Advanced Cervical Cancer, Cervical Cancer Management, Cervical Cancer +10

Cardiac Radiosurgery for Malignant Ventricular Tachycardia

Jakub Cvek, R Neuwirth, Lukáš Knybel et al. · Cureus · 2014 · 84 citations · Full text

Cardiogenic Shock, Cardiac Anaesthesia, Health Sciences +14